168 related articles for article (PubMed ID: 10959902)
1. Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors.
Rodriguez-Galindo C; Poquette CA; Marina NM; Head DR; Cain A; Meyer WH; Santana VM; Pappo AS
J Pediatr Hematol Oncol; 2000; 22(4):321-9. PubMed ID: 10959902
[TBL] [Abstract][Full Text] [Related]
2. Second cancers in patients with the Ewing sarcoma family of tumours.
Navid F; Billups C; Liu T; Krasin MJ; Rodriguez-Galindo C
Eur J Cancer; 2008 May; 44(7):983-91. PubMed ID: 18353632
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
[TBL] [Abstract][Full Text] [Related]
4. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T
Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy.
Wexler LH; Weaver-McClure L; Steinberg SM; Jacobson J; Jarosinski P; Avila N; Pizzo PA; Horowitz ME
J Clin Oncol; 1996 Mar; 14(3):901-10. PubMed ID: 8622038
[TBL] [Abstract][Full Text] [Related]
6. Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Paulussen M; Ahrens S; Lehnert M; Taeger D; Hense HW; Wagner A; Dunst J; Harms D; Reiter A; Henze G; Niemeyer C; Göbel U; Kremens B; Fölsch UR; Aulitzky WE; Voûte PA; Zoubek A; Jürgens H
Ann Oncol; 2001 Nov; 12(11):1619-30. PubMed ID: 11822764
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment.
Relling MV; Boyett JM; Blanco JG; Raimondi S; Behm FG; Sandlund JT; Rivera GK; Kun LE; Evans WE; Pui CH
Blood; 2003 May; 101(10):3862-7. PubMed ID: 12531808
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
[TBL] [Abstract][Full Text] [Related]
9. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors.
Kushner BH; Heller G; Cheung NK; Wollner N; Kramer K; Bajorin D; Polyak T; Meyers PA
J Clin Oncol; 1998 Sep; 16(9):3016-20. PubMed ID: 9738570
[TBL] [Abstract][Full Text] [Related]
10. Macrocytosis associated with divalproex treatment.
Tsivkin R; Saito E; Kafantaris V
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1011-4. PubMed ID: 16379522
[TBL] [Abstract][Full Text] [Related]
11. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.
Barnard DR; Lange B; Alonzo TA; Buckley J; Kobrinsky JN; Gold S; Neudorf S; Sanders J; Burden L; Woods WG
Blood; 2002 Jul; 100(2):427-34. PubMed ID: 12091332
[TBL] [Abstract][Full Text] [Related]
15. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
16. High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
Pedersen-Bjergaard J; Pedersen M; Myhre J; Geisler C
Leukemia; 1997 Oct; 11(10):1654-60. PubMed ID: 9324285
[TBL] [Abstract][Full Text] [Related]
17. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
18. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
[TBL] [Abstract][Full Text] [Related]
19. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
20. Second malignancies in patients treated for Ewing sarcoma: A systematic review.
Caruso J; Shulman DS; DuBois SG
Pediatr Blood Cancer; 2019 Nov; 66(11):e27938. PubMed ID: 31347793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]